BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Clinical Outcome
7 results:

  • 1. C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer.
    Lang C; Megyesfalvi Z; Lantos A; Oberndorfer F; Hoda MA; Solta A; Ferencz B; Fillinger J; Solyom-Tisza A; Querner AS; Egger F; Boettiger K; Klikovits T; Timelthaler G; Renyi-Vamos F; Aigner C; Hoetzenecker K; Laszlo V; Schelch K; Dome B
    World J Surg Oncol; 2024 Feb; 22(1):57. PubMed ID: 38369463
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan.
    Baba T; Kusumoto M; Kato T; Kurihara Y; Sasaki S; Oikado K; Saito Y; Endo M; Fujiwara Y; Kenmotsu H; Sata M; Takano T; Kato K; Hirata K; Katagiri T; Saito H; Kuwano K
    Int J Clin Oncol; 2023 Dec; 28(12):1585-1596. PubMed ID: 37787866
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The classification of neuroendocrine neoplasms of the lung and digestive system according to WHO, 5th edition: similarities, differences, challenges, and unmet needs.
    Sanguedolce F; Zanelli M; Palicelli A; Cavazza A; DE Marco L; Zizzo M; Ascani S; Landriscina M; Giordano G; Sollitto F; Loizzi D
    Panminerva Med; 2022 Jun; 64(2):259-264. PubMed ID: 35146989
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Autoimmune encephalitis, clinical, radiological and immunological data].
    Aupy J; Collongues N; Blanc F; Tranchant C; Hirsch E; De Seze J
    Rev Neurol (Paris); 2013 Feb; 169(2):142-53. PubMed ID: 23099105
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.
    Lee SM; Khan I; Upadhyay S; Lewanski C; Falk S; Skailes G; Marshall E; Woll PJ; Hatton M; Lal R; Jones R; Toy E; Chao D; Middleton G; Bulley S; Ngai Y; Rudd R; Hackshaw A; Boshoff C
    Lancet Oncol; 2012 Nov; 13(11):1161-70. PubMed ID: 23078958
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.